MetaADEDB 2.0 @ LMMD
Axillary vein thrombosis
(UMLS:C0574014)
UMLS ID:
C0574014
MeSH ID:
N/A
Synonym(s)
1.
Axillary vein thrombosis
2.
AXILLARY VEIN THROMBOSIS
3.
thrombosis of axillary veins
4.
venous thrombosis axillary veins
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1RivaroxabanFAERS: 6US FAERS
2NuvaRingFAERS: 4US FAERS
3DecitabineFAERS: 3US FAERS
4ponatinibFAERS: 3US FAERS
5rofecoxibFAERS: 3US FAERS
6OlanzapineFAERS: 2US FAERS
7TeriparatideFAERS: 2US FAERS
8DabigatranFAERS: 1US FAERS
9DesogestrelFAERS: 1OFFSIDES
US FAERS
10FluorouracilFAERS: 1OFFSIDES
US FAERS
11GanciclovirFAERS: 1US FAERS
12IopamidolFAERS: 1US FAERS
13LenalidomideFAERS: 1US FAERS
14MemantineFAERS: 1US FAERS
15Norethindrone acetate and ethinyl estradiolFAERS: 1US FAERS
16NorethindroneFAERS: 1US FAERS
17NorgestrelFAERS: 1US FAERS
18TacrolimusFAERS: 1US FAERS
19WarfarinFAERS: 1US FAERS
20drospirenone and ethinyl estradiol combinationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
21estradiol, norethindrone drug combinationFAERS: 1US FAERS
22etonogestrelFAERS: 1US FAERS
23gemcitabineFAERS: 1US FAERS
24reviparinFAERS: 1US FAERS
25sibutramineFAERS: 1US FAERS
26BleomycinOFFSIDES
27BupropionOFFSIDES
28EnalaprilOFFSIDES
29EpinephrineOFFSIDES
30ImipenemOFFSIDES
31KetamineOFFSIDES
32LabetalolOFFSIDES
33Lanthanum carbonate hydrateOFFSIDES
34LeucovorinOFFSIDES
35MethocarbamolOFFSIDES
36MidazolamOFFSIDES
37RibavirinOFFSIDES
38Salmeterol XinafoateOFFSIDES
39Salmeterol XinafoateOFFSIDES
40SumatriptanOFFSIDES
41TheophyllineOFFSIDES
42Vecuronium BromideOFFSIDES
43VinorelbineOFFSIDES
44argatrobanOFFSIDES
45efavirenzOFFSIDES
46gadoversetamideOFFSIDES
47paricalcitolOFFSIDES
48telmisartan, hydrochlorothiazide drug combinationOFFSIDES
49treprostinilOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.